The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pritumumab binding to glioma cells induces ADCC and inhibits tumor growth.
 
Santosh Kesari
Stock and Other Ownership Interests - Curtana; Nascent Biotech
Honoraria - Caris Life Sciences; Guardant Health; Novocure; UCB
Consulting or Advisory Role - Curtana; Nascent Biotech; Nativis
Speakers' Bureau - Caris Life Sciences; Novocure; UCB
Research Funding - Abbvie; Boehringer Ingelheim; EpicentRx; ImmunoCellular Therapeutics; Inspire Pharmaceuticals; Kadmon; Lilly; Nativis; Novocure; Orbus Therapeutics; Sunovion; Triphase Accelerator Corp
Patents, Royalties, Other Intellectual Property - Curtana
 
Ivan Babic
No Relationships to Disclose
 
Rajesh Mukthavaram
No Relationships to Disclose
 
Pengfei Jiang
No Relationships to Disclose
 
Natsuko Nomura
No Relationships to Disclose
 
Sandeep C. Pingle
No Relationships to Disclose
 
Tiffany Juarez
No Relationships to Disclose
 
Junbao Yang
No Relationships to Disclose
 
Venkata Yenugonda
No Relationships to Disclose
 
Elmar Nurmemmedov
No Relationships to Disclose
 
Mark Charles Glassy
Employment - Nascent Biotech
Stock and Other Ownership Interests - Nascent Biotech
Research Funding - Nascent Biotech
Patents, Royalties, Other Intellectual Property - Nascent Biotech
Travel, Accommodations, Expenses - Nascent Biotech